AstraZeneca Agrees to Settle Seroquel Claims for $198 Million

Before you go, we thought you'd like these...
Before you go close icon

AstraZeneca (AZN) announced Monday it had reached agreements to settle approximately 17,500 Seroquel product liability suits in the U.S. for some $198 million. The suits allege that anti-psychotic Seroquel causes weight-gain diabetes in some patients.

The agreements in principle are subject to finalization of non-monetary terms, the company added.

The company said it made no provisions as of the end of the last quarter, but that any provision would not affect core earnings. Astra reiterated its core earnings per share guidance for 2010 at $6.35 to $6.65.

Previously, the London-based pharmaceutical company agreed to pay at least $55 million to resolve more than 5,500 cases alleging the company knew about Seroquel's risks but failed to adequately warn patients, Bloomberg reported. The average payments so far are $10,000 to $11,000 for former Seroquel users.

The schizophrenia and bipolar disorder drug had worldwide sales of $4.9 billion in 2009, accounting for 15% of AstraZeneca's revenue.

Read Full Story

Want more news like this?

Sign up for Finance Report by AOL and get everything from business news to personal finance tips delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

From Our Partners